Experimental CAR-T therapy tested in one patient for Hard-to-Treat myeloma
Disease control
Terminated
This study tested a new CAR-T cell therapy in one person with multiple myeloma that had come back or stopped responding to other treatments. The goal was to see if the treatment was safe and could shrink the cancer. The study was stopped early, so results are very limited.
Phase: NA • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated May 17, 2026 06:49 UTC